Free Trial

Lexeo Therapeutics (LXEO) Earnings Date, Estimates & Call Transcripts

Lexeo Therapeutics logo
$3.53 +0.24 (+7.29%)
As of 05/20/2025 04:00 PM Eastern

Lexeo Therapeutics Earnings Summary

Lexeo Therapeutics issued Q1 2025 earnings on May 12, 2025, reporting an EPS of -$0.99, which missed analysts' consensus estimates of -$0.80 by $0.19. With a trailing EPS of -$3.30, Lexeo Therapeutics' earnings are expected to grow next year, from ($3.14) to ($2.78) per share.

Latest Q1
Earnings Date
May. 12Estimated
Consensus EPS
(May. 12)
-$0.80
Actual EPS
(May. 12)
-$0.99 Missed By -$0.19

Q1 2025 Earnings Resources

Get Lexeo Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lexeo Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

LXEO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Lexeo Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.80-$0.78-$0.79
Q2 20252-$0.82-$0.80-$0.81
Q3 20252-$0.82-$0.73-$0.78
Q4 20252-$0.66-$0.66-$0.66
FY 2025 8 -$3.10 -$2.97 -$3.04
Q1 20261-$0.62-$0.62-$0.62
Q2 20261-$0.63-$0.63-$0.63
Q3 20261-$0.64-$0.64-$0.64
Q4 20261-$0.65-$0.65-$0.65

Lexeo Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/12/2025Q1 2025-$0.80-$0.99 -$0.19-$0.99--
3/24/2025Q4 2024-$0.87-$0.78+$0.09-$0.78--
8/12/2024--$0.64-$0.64--$0.64--
5/9/2024Q1 2024-$0.76-$0.77 -$0.01-$0.77--
3/11/2024Q4 2023-$0.71-$0.86 -$0.15-$0.86--
12/11/2023Q3 2023-$0.96-$12.36 -$11.40-$12.36--
10/30/2023Q2 2023--$8.30 -$8.30-$8.30--

Lexeo Therapeutics Earnings - Frequently Asked Questions

Lexeo Therapeutics (NASDAQ:LXEO) last announced its quarterly earning data on Monday, May 12, 2025. Learn more on LXEO's earnings history.

In the previous quarter, Lexeo Therapeutics (NASDAQ:LXEO) missed the analysts' consensus estimate of ($0.80) by $0.19 with a reported earnings per share (EPS) of ($0.99). Learn more on analysts' earnings estimate vs. LXEO's actual earnings.

Lexeo Therapeutics (NASDAQ:LXEO) has a recorded annual revenue of $650,000.00.

Lexeo Therapeutics (NASDAQ:LXEO) has a recorded net income of -$66.39 million. LXEO has generated -$3.30 earnings per share over the last four quarters.

Lexeo Therapeutics's earnings are expected to grow from ($3.14) per share to ($2.78) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:LXEO) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners